Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

SPA filing for phase III study of Xyotax plus carboplatin in women with NSCLC

March 22, 2007

Pain Therapeutics cleared for Israeli phase I metastatic melanoma study

March 22, 2007

CUV-1647 to be studied for prevention of phototoxicity in PDT

March 22, 2007

Targeted nanoparticles found effective in premalignant epithelial neoplasia

March 22, 2007

Interferon/gemcitabine-based adjuvant therapy improves survival, toxicity remains a concern

March 22, 2007

Myxoma virus: A novel viral oncolytic approach in hard to treat cancers

March 22, 2007

Novel radiolabeled Affibody conjugate shows antitumor efficacy in vivo

March 21, 2007

Natural fungal product shows antimyeloma activity in vitro and in vivo

March 21, 2007

Multimodal therapy with TNFerade suggested for cholangiocarcinoma

March 21, 2007

NKDCs suggested as a candidate immunotherapy for lung metastases

March 21, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...